- Home
- QTRX vs SOPH Comparison
QTRX vs SOPH Comparison
Compare QTRX & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QTRX
- SOPH
- Stock Information
- Founded
- QTRX 2007
- SOPH 2011
- Country
- QTRX United States
- SOPH Switzerland
- Employees
- QTRX N/A
- SOPH N/A
- Industry
- QTRX Biotechnology: Laboratory Analytical Instruments
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- QTRX Industrials
- SOPH Health Care
- Exchange
- QTRX Nasdaq
- SOPH Nasdaq
- Market Cap
- QTRX 241.2M
- SOPH 231.8M
- IPO Year
- QTRX 2017
- SOPH 2021
- Fundamental
- Price
- QTRX $5.95
- SOPH $4.44
- Analyst Decision
- QTRX Hold
- SOPH
- Analyst Count
- QTRX 4
- SOPH 0
- Target Price
- QTRX $11.75
- SOPH N/A
- AVG Volume (30 Days)
- QTRX 425.0K
- SOPH 131.5K
- Earning Date
- QTRX 11-11-2025
- SOPH 11-04-2025
- Dividend Yield
- QTRX N/A
- SOPH N/A
- EPS Growth
- QTRX N/A
- SOPH N/A
- EPS
- QTRX N/A
- SOPH N/A
- Revenue
- QTRX $125,784,000.00
- SOPH $69,688,000.00
- Revenue This Year
- QTRX N/A
- SOPH $16.60
- Revenue Next Year
- QTRX $37.89
- SOPH $19.09
- P/E Ratio
- QTRX N/A
- SOPH N/A
- Revenue Growth
- QTRX N/A
- SOPH 7.32
- 52 Week Low
- QTRX $4.05
- SOPH $2.58
- 52 Week High
- QTRX $15.67
- SOPH $4.92
- Technical
- Relative Strength Index (RSI)
- QTRX 60.51
- SOPH 58.04
- Support Level
- QTRX $5.60
- SOPH $3.93
- Resistance Level
- QTRX $6.20
- SOPH $4.71
- Average True Range (ATR)
- QTRX 0.33
- SOPH 0.38
- MACD
- QTRX 0.01
- SOPH -0.02
- Stochastic Oscillator
- QTRX 73.44
- SOPH 54.20
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.